152 related articles for article (PubMed ID: 21953577)
1. Increases of pentraxin 3 plasma levels in patients with Parkinson's disease.
Lee HW; Choi J; Suk K
Mov Disord; 2011 Nov; 26(13):2364-70. PubMed ID: 21953577
[TBL] [Abstract][Full Text] [Related]
2. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between cognitive impairment and plasma levels of clusterin/ApoJ in Parkinson disease patients not affected by dementia].
Niccoli Asabella A; Ruggeri M; Rubini D; Polimeno L; Spinelli C; Polito M; Pennelli M; Altini C; De Caro MS; Defazio G; Rubini G
Recenti Prog Med; 2013; 104(7-8):393-7. PubMed ID: 24042414
[TBL] [Abstract][Full Text] [Related]
4. Clock test deficits related to the global cognitive state in Alzheimer's and Parkinson's disease.
Saur R; Maier C; Milian M; Riedel E; Berg D; Liepelt-Scarfone I; Leyhe T
Dement Geriatr Cogn Disord; 2012; 33(1):59-72. PubMed ID: 22415211
[TBL] [Abstract][Full Text] [Related]
5. Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease.
Lin YS; Lee WJ; Wang SJ; Fuh JL
Sci Rep; 2018 Nov; 8(1):17368. PubMed ID: 30478269
[TBL] [Abstract][Full Text] [Related]
6. Thyroid status and cognitive function in euthyroid patients with early Parkinson's disease.
Choi SM; Kim BC; Choi KH; Nam TS; Kim JT; Lee SH; Park MS; Kim MK; Cho KH
Dement Geriatr Cogn Disord; 2014; 38(3-4):178-85. PubMed ID: 24732425
[TBL] [Abstract][Full Text] [Related]
7. Association between plasma neurofilament light chain levels and cognitive function in patients with Parkinson's disease.
Zhu Y; Yang B; Wang F; Liu B; Li K; Yin K; Yin WF; Zhou C; Tian S; Ren H; Pang A; Yang X
J Neuroimmunol; 2021 Sep; 358():577662. PubMed ID: 34311152
[TBL] [Abstract][Full Text] [Related]
8. The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease.
Dursun E; Gezen-Ak D; Hanağası H; Bilgiç B; Lohmann E; Ertan S; Atasoy İL; Alaylıoğlu M; Araz ÖS; Önal B; Gündüz A; Apaydın H; Kızıltan G; Ulutin T; Gürvit H; Yılmazer S
J Neuroimmunol; 2015 Jun; 283():50-7. PubMed ID: 26004156
[TBL] [Abstract][Full Text] [Related]
9. Plasma insulin-like growth factor 1 is associated with cognitive impairment in Parkinson's disease.
Ma J; Jiang Q; Xu J; Sun Q; Qiao Y; Chen W; Wu Y; Wang Y; Xiao Q; Liu J; Tang H; Chen S
Dement Geriatr Cogn Disord; 2015; 39(5-6):251-6. PubMed ID: 25661865
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease.
Rocha NP; Teixeira AL; Scalzo PL; Barbosa IG; de Sousa MS; Morato IB; Vieira EL; Christo PP; Palotás A; Reis HJ
Mov Disord; 2014 Apr; 29(4):527-31. PubMed ID: 24301904
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychological deficits associated with driving performance in Parkinson's and Alzheimer's disease.
Grace J; Amick MM; D'Abreu A; Festa EK; Heindel WC; Ott BR
J Int Neuropsychol Soc; 2005 Oct; 11(6):766-75. PubMed ID: 16248912
[TBL] [Abstract][Full Text] [Related]
12. Plasma α-synuclein predicts cognitive decline in Parkinson's disease.
Lin CH; Yang SY; Horng HE; Yang CC; Chieh JJ; Chen HH; Liu BH; Chiu MJ
J Neurol Neurosurg Psychiatry; 2017 Oct; 88(10):818-824. PubMed ID: 28550072
[TBL] [Abstract][Full Text] [Related]
13. Measuring functional impact of cognitive impairment: validation of the Parkinson's disease cognitive functional rating scale.
Kulisevsky J; Fernández de Bobadilla R; Pagonabarraga J; Martínez-Horta S; Campolongo A; García-Sánchez C; Pascual-Sedano B; Ribosa-Nogué R; Villa-Bonomo C
Parkinsonism Relat Disord; 2013 Sep; 19(9):812-7. PubMed ID: 23773412
[TBL] [Abstract][Full Text] [Related]
14. Instrumental activities of daily living in Parkinson's disease dementia as compared with Alzheimer's disease: relationship to motor disability and cognitive deficits: a pilot study.
Rasovska H; Rektorova I
J Neurol Sci; 2011 Nov; 310(1-2):279-82. PubMed ID: 21851954
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease-cognitive rating scale: psychometrics for mild cognitive impairment.
Fernández de Bobadilla R; Pagonabarraga J; Martínez-Horta S; Pascual-Sedano B; Campolongo A; Kulisevsky J
Mov Disord; 2013 Sep; 28(10):1376-83. PubMed ID: 23873810
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease and dementia: a longitudinal study (DEMPARK).
Balzer-Geldsetzer M; Costa AS; Kronenbürger M; Schulz JB; Röske S; Spottke A; Wüllner U; Klockgether T; Storch A; Schneider C; Riedel O; Wittchen HU; Seifried C; Hilker R; Schmidt N; Witt K; Deuschl G; Mollenhauer B; Trenkwalder C; Liepelt-Scarfone I; Gräber-Sultan S; Berg D; Gasser T; Kalbe E; Bodden M; Oertel WH; Dodel R
Neuroepidemiology; 2011; 37(3-4):168-76. PubMed ID: 22067139
[TBL] [Abstract][Full Text] [Related]
17. Increased plasma orexin-A concentrations are associated with the non-motor symptoms in Parkinson's disease patients.
Huang S; Zhao Z; Ma J; Hu S; Li L; Wang Z; Sun W; Shi X; Li M; Zheng J
Neurosci Lett; 2021 Jan; 741():135480. PubMed ID: 33161104
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
[TBL] [Abstract][Full Text] [Related]
19. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease.
Torres LL; Quaglio NB; de Souza GT; Garcia RT; Dati LM; Moreira WL; Loureiro AP; de Souza-Talarico JN; Smid J; Porto CS; Bottino CM; Nitrini R; Barros SB; Camarini R; Marcourakis T
J Alzheimers Dis; 2011; 26(1):59-68. PubMed ID: 21593563
[TBL] [Abstract][Full Text] [Related]
20. Comparison of activities of daily living impairments in Parkinson's disease patients as defined by the Pill Questionnaire and assessments by neurologists.
Lee WJ; Chang YY; Lin JJ; Sung YF; Li JY; Wang SJ; Chen RS; Yang YH; Hu CJ; Tsai CH; Wang HC; Wu SL; Chang MH; Fuh JL
J Neurol Neurosurg Psychiatry; 2014 Sep; 85(9):969-73. PubMed ID: 24218526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
